A detailed history of Motco transactions in Amgen Inc stock. As of the latest transaction made, Motco holds 523 shares of AMGN stock, worth $165,268. This represents 0.02% of its overall portfolio holdings.

Number of Shares
523
Previous 544 3.86%
Holding current value
$165,268
Previous $154,000 5.84%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $5,517 - $6,705
-21 Reduced 3.86%
523 $163,000
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $268 - $324
-1 Reduced 0.18%
544 $154,000
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $48,583 - $54,807
-190 Reduced 25.85%
545 $156,000
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $17,492 - $21,716
80 Added 12.21%
735 $197,000
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $5.69 Million - $6.73 Million
-26,572 Reduced 97.59%
655 $145,000
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $28,675 - $34,950
-127 Reduced 0.46%
27,227 $6.58 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $330,261 - $419,636
-1,442 Reduced 5.01%
27,354 $7.18 Million
Q3 2022

Nov 03, 2022

BUY
$224.46 - $253.15 $22,670 - $25,568
101 Added 0.35%
28,796 $6.49 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $248,936 - $277,022
1,079 Added 3.91%
28,695 $6.98 Million
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $217,954 - $241,114
994 Added 3.73%
27,616 $6.68 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $5.22 Million - $5.98 Million
26,266 Added 7378.09%
26,622 $5.99 Million
Q3 2021

Oct 29, 2021

BUY
$212.27 - $248.7 $20,590 - $24,123
97 Added 37.45%
356 $76,000
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $8,175 - $9,069
35 Added 15.63%
259 $63,000
Q1 2021

Apr 16, 2021

SELL
$221.91 - $258.6 $56,587 - $65,943
-255 Reduced 53.24%
224 $56,000
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $28,778 - $34,270
-133 Reduced 21.73%
479 $110,000
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $5.74 Million - $6.39 Million
-24,481 Reduced 97.56%
612 $156,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $245,680 - $301,483
-1,242 Reduced 4.72%
25,093 $5.92 Million
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $56,312 - $74,685
309 Added 1.19%
26,335 $5.34 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $81,927 - $105,305
-433 Reduced 1.64%
26,026 $6.27 Million
Q3 2019

Nov 05, 2019

SELL
$174.11 - $208.62 $454,427 - $544,498
-2,610 Reduced 8.98%
26,459 $5.12 Million
Q2 2019

Aug 07, 2019

BUY
$166.7 - $195.41 $298,559 - $349,979
1,791 Added 6.57%
29,069 $5.36 Million
Q1 2019

May 02, 2019

BUY
$180.87 - $203.88 $111,777 - $125,997
618 Added 2.32%
27,278 $5.18 Million
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $178,935 - $208,874
-1,003 Reduced 3.63%
26,660 $5.19 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $3,520 - $3,968
-19 Reduced 0.07%
27,663 $5.73 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $68,412 - $76,842
412 Added 1.51%
27,682 $5.11 Million
Q1 2018

May 08, 2018

BUY
$169.43 - $198.0 $171,802 - $200,772
1,014 Added 3.86%
27,270 $4.65 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $71,904 - $80,339
-426 Reduced 1.6%
26,256 $4.57 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $97,697 - $111,544
584 Added 2.24%
26,682 $4.98 Million
Q2 2017

Aug 08, 2017

BUY
N/A
26,098
26,098 $4.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Motco Portfolio

Follow Motco and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.